Globally recognized cannabis brand Dosist will debut in New York and Florida as well as international markets, including Canada, following its acquisition by Los Angeles-based Final Bell Holdings International Ltd.

Why It Matters

Final Bell’s acquisition of Dosist allows the company to fast-track consumer access to the trusted brand’s targeted formulas, proprietary award-winning dose-controlled devices, and fast-acting gummies into markets that have long sought its sleek hardware and platform of precision dosing.

"With this strategic acquisition, we are poised to advance the founding mission of dosist – established in 2016 – to solidify our status as the premier global cannabis brand, synonymous with trust," Jason DeLand, the founder of dosist said. “As we embrace the forthcoming phases …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.